Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Nasal Expiratory Resistance in Patients With Sleep Apnea and Expiratory Flow Limitation

NCT: NCT02612038 · WITHDRAWN

NCT IDNCT02612038
StatusWITHDRAWN
Start Date2016-05-01
Completion2017-05-01
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

Obstructive sleep apnea (OSA) is inherently site-specific. In a physiological controlled intervention study, the investigators seek to determine whether applying expiratory resistance can acutely improve ventilation and sleep in patients with expiratory flow limitation (EFL).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑